Related Experiment Video
Updated: Aug 19, 2026
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Differential proteomic analysis of proteins induced by glucocorticoids in cultured murine podocytes
Richard F Ransom1, Virginia Vega-Warner, William E Smoyer
1Pediatric Nephrology Division, University of Michigan, Ann Arbor, Michigan 48109, USA. rransom@umich.edu
Background:
The glomerular podocyte is the kidney cell most affected during the development of nephrotic syndrome, and mutations in podocyte proteins are responsible for a variety of inherited forms of nephrotic syndrome. Although glucocorticoids are a primary treatment for nephrotic syndrome, neither their target cell nor mechanism of action are known. In order to describe the proteome of the podocyte, and to identify podocyte proteins whose expression is altered by glucocorticoids, we performed a differential proteomic analysis of control and dexamethasone-treated cultured murine podocytes.
Methods:
Podocyte proteins were separated by two-dimensional-polyacrylamide gel electrophoresis (PAGE) and identified by matrix-assisted laser desorption time-of-flight (MALDI-TOF) mass spectrometry and peptide fingerprinting. Comparisons of stained two-dimensional-PAGE separations were used to identify proteins whose expression was altered by treatment with the glucocorticoid dexamethasone, and these results were confirmed by quantitative Western blotting.
Results:
A total of 106 protein spots yielded MALDI-TOF results, and 92 were identified by protein fingerprinting. Of the 88 unique proteins and four protein isoforms identified, six proteins were found whose expression was altered by dexamethasone. The proteome of cultured murine podocytes is particularly rich in actin cytoskeletal proteins and proteins involved in responses to cellular stress. The change in expression of three proteins [ciliary neurotrophic factor (CNTF), alphaB-crystallin, and heat shock protein 27 (hsp27)] was confirmed by quantitative Western blotting.
Conclusion:
Three proteins with known roles in protecting cells from injury were up-regulated by dexamethasone, demonstrating that glucocorticoids exert a direct effect on cultured podocytes resulting in changes in the expression of proteins with potential relevance to the therapeutic action of glucocorticoids in diseases such as nephrotic syndrome.
Insights
Glucocorticoids directly impact kidney podocytes, altering protein expression. This study identified three protective proteins upregulated by dexamethasone, offering insights into nephrotic syndrome treatment.
Area of Science:
- Nephrology
- Proteomics
- Molecular Biology
Background:
- Glomerular podocytes are key in nephrotic syndrome.
- Glucocorticoids treat nephrotic syndrome, but their targets and mechanisms are unknown.
- Understanding podocyte proteome is crucial for nephrotic syndrome research.
Purpose of the Study:
- To characterize the podocyte proteome.
- To identify podocyte proteins affected by glucocorticoids.
- To elucidate glucocorticoid mechanisms in podocyte function.
Main Methods:
- Differential proteomic analysis of cultured murine podocytes.
- Two-dimensional-PAGE, MALDI-TOF mass spectrometry, and peptide fingerprinting for protein identification.
- Quantitative Western blotting to confirm expression changes.
Main Results:
- Identified 88 unique proteins and four isoforms in podocytes.
- Found six proteins with altered expression after dexamethasone treatment.
- Confirmed upregulation of ciliary neurotrophic factor (CNTF), alphaB-crystallin, and heat shock protein 27 (hsp27).
Conclusions:
- Dexamethasone directly affects cultured podocytes.
- Glucocorticoids upregulate proteins involved in cellular protection.
- These findings suggest a mechanism for glucocorticoid therapy in nephrotic syndrome.
